Correlation Between Century Therapeutics and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Royalty Pharma Plc, you can compare the effects of market volatilities on Century Therapeutics and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Royalty Pharma.
Diversification Opportunities for Century Therapeutics and Royalty Pharma
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Century and Royalty is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Royalty Pharma go up and down completely randomly.
Pair Corralation between Century Therapeutics and Royalty Pharma
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Royalty Pharma. In addition to that, Century Therapeutics is 4.41 times more volatile than Royalty Pharma Plc. It trades about -0.13 of its total potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.1 per unit of volatility. If you would invest 2,704 in Royalty Pharma Plc on August 27, 2024 and sell it today you would lose (61.00) from holding Royalty Pharma Plc or give up 2.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Royalty Pharma Plc
Performance |
| Timeline |
| Century Therapeutics |
| Royalty Pharma Plc |
Century Therapeutics and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Royalty Pharma
The main advantage of trading using opposite Century Therapeutics and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. Scpharmaceuticals | Century Therapeutics vs. Milestone Pharmaceuticals |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |